Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Apogee Therapeutics Inc. Common Stock
APGE | US
85.61
USD-2.68
-3.04%
APGE | US
Loading StockChartView...
About Apogee Therapeutics Inc. Common Stock
Sector
BBG01H51WYQ5
Industry
BBG01H51WYQ5
Earnings date
30/06/2024
As of date
24/04/2026
Close
85.61
Open
88.62
High
88.64
Low
84.88
View Less
APGE | US
Risk
41.1
Sharpe
2.19
Luna's Score
55/100
Recommendation
Hold
Luna says (APGE | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
Midcap (2B - 10B USD)
High Short percentage (> 15%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
26.8%1 month
41.1%3 months
66.6%6 months
55.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.92
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
-
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
4.85B
MarketCap(USD)
4.85B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-26.73
Short ratio
14.68
Short perc.
18.79
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
10.44
Range1M
21.34
Range3M
34.97
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.62
Price X volume
44.04M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | - | - |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | - | - |
| Price to Book | 3.92 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 66.57 | - | - |
| Debt to Equity | 0.01 | - | - |
| Debt to Assets | 0.01 | - | - |
| Market Cap | 4.85B | - | - |
